logo

Sonnet to merge into Hyperliquid Strategies, holding 12.6 million HYPE tokens and $300 million in cash

By: odaily.com|2025/07/14 11:31:37

Odaily News Nasdaq-listed Sonnet BioTherapeutics announced that it will merge with Rorschach I LLC to form Hyperliquid Strategies and launch a crypto treasury strategy. The new entity will be renamed Hyperliquid Strategies and is expected to hold 12.6 million HYPE tokens and $305 million in cash, with a total valuation of approximately $888 million.
Rorschach I LLC was jointly established by Atlas Merchant Capital and Paradigm Operations and other sponsors. After the merger is completed, Hyperliquid Strategies will continue to be listed on Nasdaq and become a publicly traded company focused on crypto asset management, and the stock code will also be changed.
The transaction was supported by institutions such as Paradigm, Galaxy Digital, Pantera Capital, D1 Capital, Republic Digital and 683 Capital. (The Block)

Bitcoin y las altcoins en una encrucijada: ¿nuevos máximos o corrección entrante?
WEEX causa sensación en BlockchainRIO 2025

También te puede interesar

Compartir
copy

Ganadores

Últimas noticias sobre criptomonedas

10:53

Mainstream Perp DEX Overview: Hyperliquid Surpasses $10 Billion in Trading Volume Again, Platform Volumes Rebound Collectively

10:51

The European Stablecoin Alliance Appoints Former Coinbase Executive as Chief Executive Officer

10:28

Ethereum ICO Whale with 254,900 Tokens Nearing Liquidation, Deposited 23,000 ETH to CEX in the Past Week

10:25

The Central Bank of Russia has confirmed that it may relax cryptocurrency regulation rules.

10:22

OECD: Expects the Federal Reserve to "gradually" lower the key interest rate to 3.25% to 3.5%

Leer más
Comunitario
icon
icon
icon
icon
icon
icon
icon

Atención al cliente@weikecs

Cooperación empresarial@weikecs

Trading cuantitativo y MM[email protected]

Programa VIP[email protected]